Which statement best describes the focus of the Therapeutic Use category?

• A. Development Methodology covers development plan issues and component studies
• B. Nonclinical pharmacology testing only
• C. Clinical trial site selection and logistics
• D. Post-approval pharmacovigilance only

Answer: (A)

Therapeutic Use focuses on how a therapy is developed and intended to be used, including the overall development plan and how the therapy’s components are evaluated. That makes focusing on development plan issues and component studies the best description, since it captures the planning and assessment of the therapeutic product as a whole rather than just one aspect of safety, operations, or post‑approval monitoring.

Nonclinical pharmacology testing only would narrow to early safety and mechanism work and misses the broader development framework. Clinical trial site selection and logistics concern the practical execution of a study, not the strategic development of the therapy. Post‑approval pharmacovigilance centers on safety monitoring after approval, not on how the therapy is developed or how its components are studied.